Bond & Devick Financial Network’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Hold
8,530
0.11% 117
2026
Q1
$471K Hold
8,530
0.13% 104
2025
Q4
$418K Hold
8,530
0.12% 106
2025
Q3
$368K Buy
8,530
+2,100
+33% +$82K 0.11% 114
2025
Q2
$247K Buy
6,430
+1,100
+21% +$42K 0.08% 146
2025
Q1
$206K Sell
5,330
-2,500
-32% -$91.5K 0.07% 157
2024
Q4
$320K Hold
7,830
0.14% 121
2024
Q3
$320K Buy
7,830
+400
+5% +$16.4K 0.14% 121
2024
Q2
$286K Buy
7,430
+520
+8% +$21.9K 0.15% 117
2024
Q1
$296K Buy
6,910
+760
+12% +$31.3K 0.16% 117
2023
Q4
$228K Buy
+6,150
New +$221K 0.13% 130

Other funds holding GSK

Bond & Devick Financial Network's GSK Position: Q2 2026 in Review

Bond & Devick Financial Network held its GSK (GSK) position steady in Q2 2026 at 8,530 shares worth $447K. The position accounts for 0.11% of the portfolio, ranked #117.

Bond & Devick Financial Network first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $471K in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Bond & Devick Financial Network held 8,530 shares of GSK worth $447K as of Q2 2026.
  • Bond & Devick Financial Network left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.11% of Bond & Devick Financial Network's portfolio in Q2 2026, its #117 holding.
  • Bond & Devick Financial Network first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Bond & Devick Financial Network's GSK position peaked at $471K in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bond & Devick Financial Network's 13F filing for Q2 2026, filed 16 Jul 2026.